An emerging and promising anticancer strategy: colonization of engineered Staphylococcus epidermidis

Yanyan Liu; Yulong Cai

doi:10.1002/mco2.467

MedComm ›› 2024, Vol. 5 ›› Issue (1) :e467 DOI: 10.1002/mco2.467

HIGHLIGHT

An emerging and promising anticancer strategy: colonization of engineered Staphylococcus epidermidis

Yanyan Liu ¹
, Yulong Cai ²^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Yanyan Liu, Yulong Cai. An emerging and promising anticancer strategy: colonization of engineered Staphylococcus epidermidis. MedComm, 2024, 5(1): e467 DOI:10.1002/mco2.467

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Chen YE, Bousbaine D, Veinbachs A, et al. Engineered skin bacteria induce antitumor T cell responses against melanoma. Science. 2023;380(6641):203-210.

[2]	Harris-Tryon TA, Grice EA. Microbiota and maintenance of skin barrier function. Science. 2022;376(6596):940-945.

[3]	Kepp O, Zitvogel L, Kroemer G. Prevention and treatment of cancers by tumor antigen-expressing Staphylococcus epidermidis. Oncoimmunology. 2023;12(1):2212547.